FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
3 letters match. Newest first.
-
DrugsRemedyRepack, Inc.
RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.
High risk -
DrugsCentrient Pharmaceuticals India Private Limited
Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.
High risk -
DrugsLaboratorio Pharma International SRL
FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.
High risk